Bionomics Aktie
Personal
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 140 | 140 | 140 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,02 | 0,04 | 0,02 |
Bilanz (in Mio. AUD) - Aktiva
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 6 | 14 | 25 | 22 | 31 |
| Summe Anlagevermögen | 19 | 18 | 9 | 9 | 23 |
| Summe Aktiva | 25 | 32 | 34 | 31 | 54 |
Bilanz (in Mio. AUD) - Passiva
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 6 | 6 | 6 | 5 | 12 |
| Summe Eigenkapital | 19 | 25 | 29 | 26 | 41 |
| Summe Passiva | 25 | 32 | 34 | 31 | 54 |
Adresse
| 200 Greenhill Road, 5063 Eastwood | |
| Telefon | +61 (8) 8150-7400 |
| Internet | http://www.bionomics.com.au |
Management
|
Adrian Hinton
Financial Controller |
|
Alan David Fisher
Independent Non-Executive Chairman |
|
David Ian Wilson
Independent Non-Executive Director |
|
Jane Ryan
Independent Non-Executive Director |
|
Julie Kerner
Senior Vice President-Business Operations |
|
Liz Doolin
Senior Vice President-Clinical Development |
|
Mark A. Smith
Chief Medical Officer |
|
Matthew Brennan
VP-Business Development & Scientific Evaluation |
|
Peter Miles Winston Davies
Independent Non-Executive Director |
|
Rajeev Chandra
Secretary |
|
Spyridon Papapetropoulos
President, Chief Executive Officer & Director |
|
Timothy M. Cunningham
Chief Financial Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
